216 related articles for article (PubMed ID: 19035280)
1. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time.
Kieback DG; Delvoux B; Romano A; Ollig S; Fischer DC
Anticancer Res; 2008; 28(5A):2569-75. PubMed ID: 19035280
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter.
Tong X; Engehausen DG; Freund CT; Agoulnik I; Guo Z; Oehler MK; Kim TE; Hasenburg A; Contant CF; Woo SL; Kieback DG
Anticancer Res; 1998; 18(2A):719-25. PubMed ID: 9615711
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells.
Kieback DG
Cancer Genomics Proteomics; 2008; 5(6):311-8. PubMed ID: 19287072
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
[TBL] [Abstract][Full Text] [Related]
5. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy.
Tong XW; Engehausen DG; Kaufman RH; Agoulnik I; Contant C; Freund CT; Oehler MK; Kim TE; Hasenburg A; Woo SL; Kieback DG
Anticancer Res; 1998; 18(2A):713-8. PubMed ID: 9615710
[TBL] [Abstract][Full Text] [Related]
6. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo].
Tong X; Sei W; Gu M
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1.
Kieback DG
In Vivo; 2009; 23(1):77-80. PubMed ID: 19368128
[TBL] [Abstract][Full Text] [Related]
8. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG
Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.
Tong XW; Block A; Chen SH; Woo SL; Kieback DG
Anticancer Res; 1996; 16(4A):1611-7. PubMed ID: 8712678
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
Freund CT; Tong XW; Block A; Contant CF; Kieback DG; Rowley DR; Lerner SP
Anticancer Res; 2000; 20(5A):2811-6. PubMed ID: 11062688
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents.
Tong X; Shine DH; Agoulnik I; Freund CT; Hasenburg A; Aguilar-Cordova E; Woo SL; Kieback DG
Anticancer Res; 1998; 18(5A):3421-6. PubMed ID: 9858918
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.
You Z; Fischer DC; Tong X; Hasenburg A; Aguilar-Cordova E; Kieback DG
Cancer Gene Ther; 2001 Mar; 8(3):168-75. PubMed ID: 11332987
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model.
Terao S; Shirakawa T; Goda K; Kamidono S; Fujisawa M; Gotoh A
Anticancer Res; 2005; 25(4):2757-60. PubMed ID: 16080522
[TBL] [Abstract][Full Text] [Related]
14. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
Jiang J; Kong B; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
[TBL] [Abstract][Full Text] [Related]
15. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
16. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells].
Zhou JF; Chen G; Lu YP; Wang SX; Ma D
Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048
[TBL] [Abstract][Full Text] [Related]
17. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific transcriptional targeting of suicide gene therapy.
Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
20. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]